Resolute Oncology Inc (REON) SEC Filing 10-Q Quarterly report for the period ending Sunday, June 30, 2013

Resolute Oncology Inc

CIK: 1470022 Ticker: REON
Document and Entity Information
6 Months Ended
Jun. 30, 2013
Aug. 09, 2013
Document And Entity Information    
Entity Registrant Name RESOLUTE ONCOLOGY INC  
Entity Central Index Key 0001470022  
Document Type 10-Q  
Document Period End Date Jun. 30, 2013  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Is Entity a Well-known Seasoned Issuer? No  
Is Entity a Voluntary Filer? No  
Is Entity's Reporting Status Current? Yes  
Entity Filer Category Smaller Reporting Company  
Entity Common Stock, Shares Outstanding   41,386,000
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2013  

View differences made from one quarter to another to evaluate Resolute Oncology Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Resolute Oncology Inc.


Assess how Resolute Oncology Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Resolute Oncology Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2013 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: REON
CIK: 1470022
Form Type: 10-Q Quarterly Report
Accession Number: 0001038838-13-000323
Submitted to the SEC: Mon Aug 19 2013 2:03:13 PM EST
Accepted by the SEC: Mon Aug 19 2013
Period: Sunday, June 30, 2013
Industry: Metal Mining

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: